
浏览全部资源
扫码关注微信
1.中国中医科学院 中药研究所,北京 100700
2.沈阳药科大学,沈阳 110000
3.陕西国际商贸学院,西安 712046
吴丹,在读硕士,从事中药药理学研究,Tel:010-64014411,E-mail:3313665656@qq.com
* 王萍,博士,研究员,从事代谢组学研究,E-mail:hudielanwp@sina.com;
* 许海玉,博士,研究员,博士生导师,从事中药整合药理学研究,Tel:010-64014411,E-mail:hyxu@icmm.ac.cn
收稿日期:2020-11-27,
网络出版日期:2021-02-20,
纸质出版日期:2021-08-20
移动端阅览
吴丹,陈鸿,江红等.基于UPLC-QTOF-MS/MS和TCMIP的续断治疗类风湿性关节炎活性成分筛选及作用机制分析[J].中国实验方剂学杂志,2021,27(16):131-140.
WU Dan,CHEN Hong,JIANG Hong,et al.Screening of Active Components and Analysis of Mechanism of Dipsaci Radix in Treating Rheumatoid Arthritis Based on UPLC-QTOF-MS/MS and TCMIP[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(16):131-140.
吴丹,陈鸿,江红等.基于UPLC-QTOF-MS/MS和TCMIP的续断治疗类风湿性关节炎活性成分筛选及作用机制分析[J].中国实验方剂学杂志,2021,27(16):131-140. DOI: 10.13422/j.cnki.syfjx.20211049.
WU Dan,CHEN Hong,JIANG Hong,et al.Screening of Active Components and Analysis of Mechanism of Dipsaci Radix in Treating Rheumatoid Arthritis Based on UPLC-QTOF-MS/MS and TCMIP[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(16):131-140. DOI: 10.13422/j.cnki.syfjx.20211049.
目的
2
依托超高效液相色谱-四极杆飞行时间质谱法(UPLC-QTOF-MS/MS)和中医药整合药理学研究平台(TCMIP),探讨续断治疗类风湿性关节炎(RA)的主要活性成分和作用机制。
方法
2
采用UPLC-QTOF-MS/MS,分别在正、负离子扫描模式下对续断醇提液中的化学成分进行定性分析,流动相0.1%甲酸水溶液(A)-乙腈(B)梯度洗脱(0~10 min,0.2%~20%B;10~20 min,20%~40%B;20~25 min,40%~50%B;25~33 min,50%~98%B;33~35 min,98%~0.2%B),电喷雾电离源(ESI),扫描范围
m
/
z
50~2 000;基于TCMIP,分别获取续断、肝肾阴虚证和RA的候选靶标群,进行“病-证-方”关联分析,富集得到主要药效成分及关键作用靶标,进一步进行蛋白质-蛋白质相互作用(PPI)网络及生物功能富集分析。
结果
2
在正、负离子模式下共鉴定了续断醇提液中81个化学成分;利用TCMIP收集到这些化学成分对应的283个候选靶标,RA对应的7个疾病基因,以及肝肾阴虚证相关的215个基因。经“病-证-方”关联分析及网络拓扑特征值计算等方式最终确定了17个关键活性成分,主要为续断皂苷类、脂肪酸类成分;其主要涉及7个核心靶标,即肿瘤坏死因子(TNF),核转录因子-
κ
B亚单位1(NF-
κ
B
1
),肝细胞核因子4
α
(HNF4A),核受体亚家族3C组成员1(NR3C1),过氧化物酶体增殖物激活受体
γ
(PPARG),核受体亚家族1H组成员4(NR1H4)和核受体辅激活因子1(NCOA1),均与炎症相关,其中还有2个与胆汁酸途径相关;涉及的RA相关通路主要为PPAR
α
激活基因表达等炎症通路,以及胆汁酸合成和代谢相关通路。
结论
2
液质联用技术联合中医药大数据平台初步阐明了续断多成分对多条炎症通路和胆汁酸相关通路的调控作用,为续断治疗RA作用机制的深入阐释奠定了基础。
Objective
2
To explore active components and mechanism of Dipsaci Radix in treating rheumatoid arthritis (RA) based on ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (UPLC-QTOF-MS/MS) and Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine (TCMIP).
Method
2
UPLC-QTOF-MS/MS with electrospray ionization (ESI) was used to qualitatively analyze the chemical components in methanol extract of Dipsaci Radix under positive and negative ion scanning modes. The mobile phase consisted of 0.1% formic acid aqueous solution (A)-acetonitrile (B) for gradient elution (0-10 min, 0.2%-20%B; 10-20 min, 20%-40%B; 20-25 min, 40%-50%B; 25-33 min, 50%-98%B; 33-35 min, 98%-0.2%B), and the scanning range was
m
/
z
50-2 000. Based on TCMIP, candidate target groups of Dipsaci Radix, RA and syndrome with Yin deficiency of liver and kidney were obtained, and correlation analysis on "disease-syndrome-prescription" was used to enrich the main active components and key targets. Cytoscape 3.8.0 and STRING 11.0 database were used to construct protein-protein interaction (PPI) network diagram. Metascape platform was used to analysis gene ontology biological progress and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways.
Result
2
A total of 81 ingredients were identified by UPLC-QTOF-MS/MS. Based on TCMIP, 283 candidate targets corresponding to 81 ingredients, 7 RA related targets and 215 genes corresponding to syndrome with Yin deficiency of liver and kidney were collected. With further correlation analysis on "disease-syndrome-prescription", 17 key active ingredients were predicted, mainly including saponins and fatty acids of Dipsaci Radix. It mainly involved 7 hub targets, namely tumor necrosis factor (TNF), nuclear factor-
κ
B subunit 1 (NF-
κ
B
1
), hepatocyte nuclear factor 4 alpha (HNF4A), nuclear receptor subfamily 3 group C member 1 (NR3C1), peroxisome proliferator activated receptor gamma (PPARG), nuclear receptor subfamily 1 group H member 4 (NR1H4) and nuclear receptor coactivator 1 (NCOA1). All of them were related to inflammation, and two of them were related to bile acid pathway. The 7 hub targets and 7 pathways played an important role in RA were screen out, including 4 bile acid related pathways and 3 inflammatory related pathways.
Conclusion
2
UPLC-QTOF-MS/MS combined with TCMIP preliminarily elucidates the regulatory effect of multi-components in Dipsaci Radix on several pathways related to the inflammatory response and bile acid synthesis and metabolism, which lays a foundation for further study on the mechanism of Dipsaci Radix against RA.
SCOTT D L , WOLFE F , HUIZINGA T W . Rheumatoid arthritis [J]. Lancet , 2010 , 376 ( 9746 ): 1094 - 1108 .
FAVALLI E G , RAIMONDO M G , BECCIOLINI A , et al . The management of first-line biologic therapy failures in rheumatoid arthritis:current practice and future perspectives [J]. Autoimmun Rev , 2017 , 16 ( 12 ): 1185 - 1195 .
李满意 , 刘红艳 , 娄玉钤 . 娄多峰教授“虚邪瘀”治痹原则及用药经验 [J]. 风湿病与关节炎 , 2013 , 2 ( 12 ): 42 - 43 .
吴闵 , 姚晓玲 , 姚血明 , 等 . 类风湿关节炎中医证候分型研究进展 [J]. 风湿病与关节炎 , 2018 , 7 ( 11 ): 71 - 74 .
郑乐 , 韩隆胤 , 许舒迪 , 等 . 基于网络药理学探讨牛膝-续断药对在类风湿关节炎中的作用机制 [J]. 中国新药杂志 , 2020 , 29 ( 16 ): 1911 - 1920 .
祝乃强 , 侯静怡 , 刘釐欣 , 等 . 基于网络药理学的续断-补骨脂药对治疗骨关节炎作用机制研究 [J]. 中国现代应用药学 , 2020 , 37 ( 10 ): 1157 - 1165 .
张林华 . 基于数据挖掘的中医治疗风湿病临床用药规律与作用机制研究 [D]. 北京 : 北京中医药大学 , 2019 .
魏赈权 . 断藤益母汤对类风湿关节炎成纤维样滑膜细胞活化、迁移和侵袭的调控及其机制研究 [D]. 广州 : 广州中医药大学 , 2019 .
吉海旺 , 罗强 , 曹晓菊 , 等 . 尪痹片治疗RA(肝肾两虚兼瘀血痹阻证)临床疗效观察 [C]// 中国中西医结合学会风 . 全国第十一届中西医结合风湿病学术会议论文汇编 : 2013 年卷. 西安:出版社不详 , 2013 : 5 .
许海玉 , 刘振明 , 付岩 , 等 . 中药整合药理学计算平台的开发与应用 [J]. 中国中药杂志 , 2017 , 42 ( 18 ): 3633 - 3638 .
张琪 , 成砚萍 , 马博 , 等 . 续断总皂苷和三七总皂苷配伍对去卵巢大鼠骨质疏松症的治疗作用 [J]. 中药新药与临床药理 , 2010 , 21 ( 5 ): 502 - 505 .
FONTAINE R H , CASES O , LELIÈVRE V , et al . IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis [J]. Cell Death Differ , 2008 , 15 ( 10 ): 1542 - 1552 .
WANG X , WU H , YU W , et al . Hepatocyte nuclear factor 1b is a novel negative regulator of white adipocyte differentiation [J]. Cell Death Differ , 2017 , 24 ( 9 ): 1588 - 1597 .
BROCKER C N , KIM D , MELIA T , et al . Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting [J]. Nat Commun , 2020 , 11 ( 1 ): 5847 .
SCHUBERT K , DAMINK S W M O , BERGEN M V , et al . Interactions between bile salts,gut microbiota,and hepatic innate immunity [J]. Immunol Rev , 2017 , 279 ( 1 ): 23 - 35 .
TAO Y , HUANG S R , LI W D , et al . Simultaneous determination of ten bioactive components in raw and processed Radix Dipsaci by UPLC-Q-TOF-MS [J]. J Chromatogr Sci , 2019 , 57 ( 2 ): 122 - 129 .
LI X R , LI J , REN Q , et al . The molecular mechanism of treating osteoarthritis with dipsacus saponins by inhibiting chondrocyte apoptosis [J]. Exp Ther Med , 2017 , 14 ( 5 ): 4527 - 4532 .
ZHANG J Q , YI S N , XIAO C H , et al . Asperosaponin Ⅵ inhibits LPS-induced inflammatory response by activating PPAR- γ pathway in primary microglia [J]. Saudi J Biol Sci , 2020 , 27 ( 11 ): 3138 - 3144 .
DING X P , LI W Y , CHEN D S , et al . Asperosaponin Ⅵ stimulates osteogenic differentiation of rat adipose-derived stem cells [J]. Regen Ther , 2019 , 11 : 17 - 24 .
KWON J O , JIN W J , KIM B J , et al . Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2 [J]. Eur J Pharmacol , 2015 , 768 : 189 - 198 .
FROMMER K W , HASSELI R , SCHÄFFLER A , et al . Free fatty acids in bone pathophysiology of rheumatic diseases [J]. Front Immunol , 2019 , 10 : 2757 .
DARLINGTON L G , STONE T W . Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders [J]. Br J Nutr , 2001 , 85 ( 3 ): 251 - 269 .
CALDER P C , ZURIER R B . Polyunsaturated fatty acids and rheumatoid arthritis [J]. Curr Opin Clin Nutr Metab Care , 2001 , 4 ( 2 ): 115 - 121 .
SALINAS F L S , BENÍTEZ J G S , NAVARRO M D H , et al . NF- κ B 1 /IKK ε gene expression and clinical activity in patients with rheumatoid arthritis [J]. Lab Med , 2017 , 49 ( 1 ): 11 - 17 .
张磊 , 魏伟 , 常艳 , 等 . 肿瘤坏死因子- α 对胶原性关节炎大鼠滑膜细胞功能的影响及白芍总苷的作用 [J]. 中国新药杂志 , 2007 , 16 ( 7 ): 519 - 522 .
ABBASI M , MOUSAVI M J , JAMALZEHI S , et al . Strategies toward rheumatoid arthritis therapy;the old and the new [J]. J Cell Physiol , 2019 , 234 ( 7 ): 10018 - 10031 .
BAZSÓ A , KÖVESDI A , RÁSONYI R , et al . Glucocorticoid receptor polymorphisms in rheumatoid arthritis:results from a single centre [J]. Clin Exp Rheumatol , 2020 , 38 ( 5 ): 858 - 863 .
KAWAI M , ROSEN C J . PPAR γ :a circadian transcription factor in adipogenesis and osteogenesis [J]. Nat Rev Endocrinol , 2010 , 6 ( 11 ): 629 - 636 .
RUSSO L , GILLER K , PFITZNER E , et al . Insight into the molecular recognition mechanism of the coactivator NCoA1 by STAT6 [J]. Sci Rep , 2017 , 7 ( 1 ): 16845 .
GUO C S , XIE S J , CHI Z X , et al . Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome [J]. Immunity , 2016 , 45 ( 4 ): 802 - 816 .
LI L , LIU C , LIU M Q , et al . Taurochenodeoxycholic acid induces apoptosis of fibroblast-like synoviocytes [J]. Eur J Pharmacol , 2013 , 706 ( 1/3 ): 36 - 40 .
BRUUSGAARD A , ANDERSEN R B . Chenodeoxycholic-acid treatments of rheumatoid arthritis [J]. Lancet , 1976 , 1 ( 7961 ): 700 .
LEE E J , KWON J E , PAEK M J , et al . Ursodeoxycholic acid attenuates experimental autoimmune arthritis by targeting Th17 and inducing pAMPK and transcriptional corepressor SMILE [J]. Immunol Lett , 2017 , 188 : 1 - 8 .
SÁNCHEZ-MALDONADO J M , CÁLIZ R , CANET L , et al . Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression:results from the REPAIR consortium [J]. Sci Rep , 2019 , 9 : 14812 .
CARLSON A K , RAWLE R A , WALLACE C W , et al . Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers [J]. Clin Exp Rheumatol , 2019 , 37 : 393 - 399 .
0
浏览量
28
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621